CytomX Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 31.96 M | $150.19 M | 29.44% | 18.03% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 15.01 M | $70.56 M | 67.44% | 8.47% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 10.20 M | $47.95 M | 1,064.30% | 5.76% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 10.10 M | $47.46 M | 4.32% | 5.70% |
| VR ADVISER, LLC | 05/15/2026 | 9.98 M | $46.92 M | -35.85% | 5.63% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 8.73 M | $41.05 M | 100.00% | 4.93% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 7.88 M | $37.01 M | 51.76% | 4.44% |
| STATE STREET CORP | 05/15/2026 | 5.66 M | $26.62 M | 10.16% | 3.19% |
| CITADEL ADVISORS LLC | 05/15/2026 | 5.41 M | $25.41 M | 1,479.35% | 3.05% |
| BLACKROCK, INC. | 05/13/2026 | 5.23 M | $24.57 M | 42.48% | 2.95% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 4.98 M | $23.39 M | 17.06% | 2.81% |
| ELMIND CAPITAL, LP | 05/15/2026 | 4.55 M | $21.39 M | 550.00% | 2.57% |
| NEXTECH INVEST, LTD. | 05/15/2026 | 4.45 M | $20.91 M | 100.00% | 2.51% |
| MARSHALL WACE, LLP | 05/15/2026 | 4.14 M | $19.45 M | 257.68% | 2.33% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 3.66 M | $17.20 M | 1,163.65% | 2.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 3.58 M | $16.84 M | 100.00% | 2.02% |
| SIREN, L.L.C. | 05/14/2026 | 3.46 M | $16.25 M | 100.00% | 1.95% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 3.41 M | $16.03 M | -18.47% | 1.92% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 3.19 M | $14.99 M | 27.18% | 1.80% |
| UBS GROUP AG | 05/05/2026 | 3.12 M | $14.66 M | 741.60% | 1.76% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 3.07 M | $14.42 M | 12,809.71% | 1.73% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 2.71 M | $12.74 M | 73.64% | 1.53% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 2.25 M | $10.57 M | 112.00% | 1.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.07 M | $9.72 M | 35.46% | 1.17% |
| WOODLINE PARTNERS LP | 05/15/2026 | 2.00 M | $9.40 M | -14.39% | 1.13% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.93 M | $9.07 M | 49.72% | 1.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.87 M | $8.79 M | 90.47% | 1.05% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.46 M | $6.86 M | -40.68% | 0.82% |
| GILDER GAGNON HOWE & CO LLC | 05/15/2026 | 1.12 M | $5.27 M | 100.00% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.10 M | $5.18 M | 100.00% | 0.62% |
| PATIENT SQUARE CAPITAL LP | 05/15/2026 | 1.09 M | $5.10 M | 100.00% | 0.61% |
| JANE STREET GROUP, LLC | 05/12/2026 | 997.51 K | $4.69 M | 64.28% | 0.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 907.80 K | $4.27 M | 4,306.80% | 0.51% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 900.00 K | $4.23 M | 100.00% | 0.51% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 900.00 K | $4.23 M | 100.00% | 0.51% |
| ALLY BRIDGE GROUP (NY) LLC | 05/18/2026 | 900.00 K | $4.23 M | 100.00% | 0.51% |
| TREXQUANT INVESTMENT LP | 05/15/2026 | 898.77 K | $4.22 M | 100.00% | 0.51% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 05/08/2026 | 794.76 K | $3.74 M | 100.00% | 0.45% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 730.84 K | $3.43 M | -81.13% | 0.41% |
| DV TRADING LLC | 05/15/2026 | 714.00 K | $3.36 M | 100.00% | 0.40% |
| BARCLAYS PLC | 05/15/2026 | 700.00 K | $3.29 M | 100.00% | 0.39% |
| ENSIGN PEAK ADVISORS, INC | 08/18/2026 | 592.47 K | $2.78 M | 100.00% | 0.35% |
| NORTHERN TRUST CORP | 05/14/2026 | 612.14 K | $2.88 M | 47.44% | 0.35% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 606.28 K | $2.85 M | 21,361.06% | 0.34% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 573.22 K | $2.69 M | 100.00% | 0.32% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 568.56 K | $2.67 M | 34.36% | 0.32% |
| EAM INVESTORS, LLC | 05/13/2026 | 565.11 K | $2.66 M | 177.26% | 0.32% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 550.00 K | $2.59 M | 100.00% | 0.31% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 540.00 K | $2.54 M | 575.00% | 0.30% |
| EXOME ASSET MANAGEMENT LLC | 05/15/2026 | 521.47 K | $2.45 M | -30.03% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of CytomX Therapeutics Inc. The most heavily invested institutionals were:
Ethos Financial Group, LLC: 0
BALYASNY ASSET MANAGEMENT L.P.: 0
GABELLI & Co INVESTMENT ADVISERS, INC.: 0
EAM Investors, LLC: 0
Mariner, LLC: 0
Centiva Capital, LP: 0
113.50% of CytomX Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 12.90 M shares in the last 24 months. This purchase volume represents approximately $64.88 M in transactions.